COX-1 and COX-2 expression in stage I and II invasive cervical carcinoma: Relationship to disease relapse and long-term survival

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1303-1308

  Athavale, R ^a   Clooney, K ^b   O'Hagan, J ^c   Shawki, H ^d   Clark, A H ^b   Green, J A ^e  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b ARROWE PARK HOSPITAL   (United Kingdom)

^c CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cervical carcinoma; COX 1; COX 2

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ADULT; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LOG RANK TEST; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; UTERINE CERVIX CARCINOMA;

ADULT; CARCINOMA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 33745111782     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00372.x     Document Type: Article

References (32)

1. Pisani P Parkin DM Bray F Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999 83 : 18 29.
2. Eifel PJ Berek JS Thigpen JT. Cancer of the cervix, vagina and vulva. In : Rosenberg SA, ed. Cancer: principles and practice of oncology, 6th edn. Philadelphia, PA : Lippincott, Williams and Wilkins, 2001 : 1526 56.
3. Waggoner SE. Cervical cancer. Lancet 2003 361 : 2217 25.
4. Green JA Kirwan JM Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001 358 : 781 6.
5. Sedlis A Bundy BN Rotman MZ et al. A randomised trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynaecologic Oncology Group study. Gynecol Oncol 1999 73 : 177 83.
6. Kirwan JM Symonds P Green JA Tierney J Collingwood M Williams CJ. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003 68 : 217 26.
7. Hla T Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992 89 : 7384 8.
8. Herschman HR. Prostaglandin synthase 2. Biochem Biophys Acta 1996 1299 : 125 40.
9. Subbaramiah K Telang N Ramonetti JT et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996 56 : 4424 9.
10. Sales KJ Katz AA Howard B et al. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin E receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 2002 62 : 424 32 erratum in: Cancer Res 2002;62:1579 S Rader JS Zhang F et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 2001 7 : 429 34.
11. Ryu HS Chang KH Yang HW Kim MS Kwon HC Oh KS. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol Oncol 2000 76 : 320 5.
12. Gaffney DK Holden J Zempolich K Murphy KJ Dicker AP Dodson M. Elevated COX-2 expression in cervical carcinoma: reduced cause-specific survival and pelvic control. Am J Clin Oncol 2001 24 : 443 6.
13. Ferrandina G Lauriola L Zannoni GF et al. Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications. Br J Cancer 2002 87 : 1145 52.
14. Ferrandina G Lauriola L Distefano MG et al. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol 2002 20 : 973 81.
15. Adams EJ Green JA Clark AH Youngson JH. Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol 1999 52 : 75 7.
16. Van Diest PJ Van Dam P Henzen-Logmans SC et al. A scoring system for immunohistochemical staining - consensus report of the Task Force for Basic Research of the EORTC-GCCG. J Clin Pathol 1997 50 : 801 4.
17. Kim YB Kim GE Cho NH et al. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer 2002 95 : 531 9.
18. Ferrandina G Ranelletti FO Legge F et al. Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery. Int J Radiat Oncol Biol Phys 2003 55 : 21 7.
19. Kinney W Sawaya GF Sung HY Kearney KA Miller M Hiatt RA. Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening. Acta Cytol 2003 47 : 167 71.
20. Liu S Semenciw R Probert A Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer 2001 11 : 24 31.
21. Kim MH Seo SS Song YS et al. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol Oncol 2003 90 : 83 90.
22. Kodama J Seki N Tokumo K et al. Vascular endothelial growth factor is implicated in early invasion in cervical cancer. Eur J Cancer 1999 35 : 485 9.
23. Rouzer CA Kingsley PJ Wang H et al. Cyclooxygenase-1-dependent prostaglandin synthesis modulates tumor necrosis factor-alpha secretion in lipopolysaccharide-challenged murine resident peritoneal macrophages. J Biol Chem 2004 279 : 34256 68.
24. Chen YJ Wang LS Wang PH et al. High cyclooxygenase-2 expression in cervical adenocarcinomas. Gynecol Oncol 2003 88 : 379 85.
25. Kim YB Kim GE Pyo HR et al. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2004 60 : 822 9.
26. Ferrandina G Legge F Ranelletti FO et al. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer 2002 95 : 801 7.
27. Farley J Uyehara C Hashiro G Belnap C Birrer M Salminen E. Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure. Gynecol Oncol 2004 92 : 596 602.
28. Tsujii M DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995 83 : 493 501.
29. Tsujii M Kawano S Tsuji S Sawaoka H Hori M DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998 93 : 705 16.
30. Tsujii M Kawano S DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 1997 94 : 3336 40.
31. Sales KJ Katz AA Davis M et al. Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 2001 86 : 2243 9.
32. Ferrandina G Ranelletti FO Legge F et al. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study. Clin Cancer Res 2003 9 : 4324 31.